(Q34528281)

English

Effects of slow-release octreotide on urinary metanephrine excretion and plasma chromogranin A and catecholamine levels in patients with malignant or recurrent phaeochromocytoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Effects of slow-release octreotide on urinary metanephrine excretion and plasma chromogranin A and catecholamine levels in patients with malignant or recurrent phaeochromocytoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

author name string

Maxime Lamarre-Cliche

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Anne-Paule Gimenez-Roqueplo

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Eliane Billaud

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Eric Baudin

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Jean-Pierre Luton

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Pierre-François Plouin

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

publication date

1 November 2002

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

57

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

629-634

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01658.X

21 January 2018

TURNOVER AND METABOLISM OF CATECHOLAMINES IN PATIENTS WITH PHEOCHROMOCYTOMA

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01658.X

21 January 2018

Effect of octreotide on catecholamine plasma levels in patients with chromaffin cell tumors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01658.X

21 January 2018

Pheochromocytoma, a rare cause of hypertension: long-term follow-up of 55 surgically treated patients.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01658.X

21 January 2018

The biochemical techniques for detecting and establishing the presence of a pheochromocytoma. A review of ten years' experience

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01658.X

21 January 2018

Chromogranin A and the alpha-subunit of glycoprotein hormones in medullary thyroid carcinoma and phaeochromocytoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01658.X

21 January 2018

Chromogranin A in familial pheochromocytoma: diagnostic screening value, prediction of tumor mass, and post-resection kinetics indicating two-compartment distribution.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01658.X

21 January 2018

Octreotide scintigraphy and catecholamine response to an octreotide challenge in malignant phaeochromocytoma.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01658.X

21 January 2018

The Role of Somatostatin and Its Analogs in the Diagnosis and Treatment of Tumors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01658.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01658.X

21 January 2018

Clinical spectrum and outcome of functional extraadrenal paraganglioma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01658.X

21 January 2018

Treatment of malignant pheochromocytomas with 131-I metaiodobenzylguanidine and chemotherapy.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01658.X

21 January 2018

Measurement of catecholamines in biological fluids by high-performance liquid chromatography: a comparison of fluorimetric with electrochemical detection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01658.X

21 January 2018

Sandostatin LAR (microencapsulated octreotide acetate) in acromegaly: pharmacokinetic and pharmacodynamic relationships

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01658.X

21 January 2018

The urinary metanephrine-to-creatinine ratio for the diagnosis of pheochromocytoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01658.X

21 January 2018

Control of catecholamine release and blood pressure with octreotide in a patient with pheochromocytoma: a case report with in vitro studies

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01658.X

21 January 2018

Short-term effects of octreotide on blood pressure and plasma catecholamines and neuropeptide Y levels in patients with phaeochromocytoma: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01658.X

21 January 2018

Tumor recurrence and hypertension persistence after successful pheochromocytoma operation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01658.X

21 January 2018

Metyrosine and pheochromocytoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01658.X

21 January 2018

Positive correlation between urinary excretion of catecholamine metabolites and tumour mass in pheochromocytoma. Results in patients with sustained and paroxysmal hypertension and multiple endocrine neoplasia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01658.X

21 January 2018

Beneficial effects of octreotide in a patient with a metastatic paraganglioma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01658.X

21 January 2018

Diagnosis and treatment of adrenal tumours: a review of 35 years' experience

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2002.01658.X

21 January 2018

Identifiers

10.1046/J.1365-2265.2002.01658.X

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34528281&oldid=1609054753"